Nordea 1 - Stable Return Fund - HB-USD LU1032955483
Returns | Annu. Returns | Volatilities | |
---|---|---|---|
1 week | +0.1 | - | - |
4 weeks | +0.9 | - | - |
52 weeks | +3.7 | +3.7 | +5.2 |
1 mon. | +0.8 | - | - |
3 mon. | +2.3 | - | - |
6 mon. | +4.3 | - | - |
1 yr | +3 | +3 | +5.2 |
3 yrs | +6.6 | +2.1 | +6.7 |
5 yrs | +16.6 | +3.1 | +6.9 |
Max | +37.5 | +3.4 | +5.9 |
Year | Jan | Feb | Mar | Apr | Mai | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | +1.9 | +2.5 | -1.2 | +0.6 | - | - | - | - | - | - | - | - | - |
2023 | +3.7 | +1 | -1.9 | +3.2 | +2.2 | -1.2 | -1.2 | +0.4 | +1 | -2.3 | -1.3 | +1.8 | +2 |
2022 | -6.4 | -1 | - | - | - | - | - | - | -5.6 | -3.8 | +0.8 | +3.1 | +0.3 |
2021 | +11.2 | -0.3 | +0.1 | +3.5 | +0.3 | +1.3 | +1.3 | +2.5 | +0.2 | -1.6 | -1.1 | +1.8 | +2.6 |
2020 | +0.7 | +0.2 | -3 | -1.4 | +3.5 | - | -1.4 | - | +0.3 | +0.5 | -2.5 | +4.4 | +0.3 |
2019 | +11.4 | +3.3 | +1.8 | +0.8 | +0.3 | -0.9 | +1.7 | +1.4 | +0.7 | +0.4 | - | +1.3 | +0.2 |
2018 | -3.3 | +1.2 | -2.2 | -0.9 | +0.6 | -1 | - | +1.4 | +0.8 | -0.1 | -2.4 | +1.4 | -2.1 |
2017 | +4.6 | +0.2 | +2.5 | +0.5 | +0.4 | +0.3 | -0.4 | - | -0.1 | -0.3 | +0.6 | +1.1 | -0.3 |
2016 | +4.2 | +1 | +1.2 | +2.6 | -0.2 | +0.2 | +1.6 | +1.2 | -0.8 | -0.3 | -1.4 | -1.6 | +0.7 |
2015 | +2.9 | +2.6 | +0.4 | +0.8 | -0.9 | +1 | -2.9 | +2.2 | -1.9 | -0.4 | +2.1 | -0.6 | +0.6 |
2014 | - | - | - | - | - | - | - | - | - | - | - | +1.7 | +0.5 |
Net inflows / Market effect | ||||||
---|---|---|---|---|---|---|
Asset Under Management on 27/03/2024 | 02/2024 | T4/2023 | S2/2023 | 2023 | YTD | |
Fund | 4012.6 M€ | -96.6 / -58.7 | -436.6 / +98.5 | -726.6 / +33.5 | -1287.6 / +85.4 | -325.9 / +76.9 |
LU1055445297 | 47.3 M$ ( - M€ ) | -0.4 / -0.6 | -6.7 / +1.3 | -10.7 / +1 | -17.1 / +2.5 | -0.2 / +1 |
LU0227384459 | 31.2 MNOK ( - M€ ) | -0.1 / 0 | -0.2 / +0.7 | -0.1 / -1 | -6.7 / +3.4 | -2.9 / +1.7 |
LU1009765360 | 1.5 MSEK ( - M€ ) | 0 / 0 | 0 / 0 | 0 / 0 | 0 / -1.5 | 0 / 0 |
LU0255639485 | 20.3 MNOK ( - M€ ) | 0 / 0 | -1.4 / +0.5 | -3.8 / -0.7 | -5 / +1.6 | -0.5 / +1 |
LU0533600846 | 0.8 MPLN ( - M€ ) | 0 / 0 | 0 / 0 | 0 / 0 | 0 / 0 | -0.1 / 0 |
LU0227384020 | 1756.2 M€ | -45.2 / -24.3 | -228.9 / +39.1 | -357.9 / +11.6 | -592.3 / +33.4 | -134.9 / +28.9 |
LU0351545230 | 844.1 M€ | -20.5 / -11.5 | -71 / +21.2 | -146.6 / +10.3 | -319 / +26 | -86.9 / +16 |
LU0255639139 | 653.6 M€ | -16.7 / -9.1 | -46.3 / +14.4 | -86.4 / +4.7 | -152.3 / -0.4 | -49.1 / +10.8 |
LU0227385266 | 355.1 M€ | -10.7 / -5.2 | -32.2 / +7.2 | -49.1 / +1 | -81.9 / +3.5 | -29.9 / +5.2 |
LU0539147214 | 236.4 M€ | 0 / -2.8 | 0 / +5.7 | 0 / +3.7 | 0 / +7.7 | 0 / +4.7 |
LU1009762938 | 113.6 M€ | -0.1 / -1.5 | -23.2 / +2.6 | -26.3 / +1.1 | -30.2 / +0.6 | -1.7 / +2 |
LU0841554891 | 46.8 M€ | -2.4 / -0.7 | -9.7 / +1.2 | -13.5 / +0.5 | -20 / +1.4 | -6.2 / +0.9 |
LU1032955483 | 153.8 M$ ( - M€ ) | -1.2 / -2 | -10.3 / +4.1 | -22.3 / +2.7 | -43.1 / +6.8 | -12.4 / +3.1 |
LU0841555518 | 1.6 M£ ( - M€ ) | 0 / 0 | -0.2 / 0 | -0.2 / 0 | -0.6 / +0.1 | 0 / 0 |
LU0772962550 | 16.6 MCHF ( - M€ ) | +1.2 / -0.3 | -1.7 / +0.3 | -2.9 / 0 | -4.1 / 0 | +0.2 / +0.2 |
LU0227384707 | 23.4 MSEK ( - M€ ) | 0 / -0.4 | -0.5 / -0.5 | -0.9 / -1.4 | -3.8 / +0.4 | +0.2 / +1.3 |
LU0841554115 | 0.2 M£ ( - M€ ) | -0.1 / 0 | -0.2 / 0 | -0.2 / 0 | -0.2 / 0 | -0.2 / 0 |
LU0772962477 | 19.6 MCHF ( - M€ ) | 0 / -0.3 | -3 / +0.3 | -4 / -0.1 | -6.9 / -0.1 | -0.4 / +0.2 |
LU0533600689 | 0 MPLN ( - M€ ) | 0 / 0 | 0 / 0 | 0 / 0 | 0 / 0 | 0 / 0 |
LU0841555278 | 6.8 M€ | -0.3 / -0.1 | -1 / +0.2 | -1.7 / +0.1 | -4.3 / +0.1 | -0.8 / +0.1 |
Details
SRI |
| |||||||
---|---|---|---|---|---|---|---|---|
Currency | USD | |||||||
Holding perdiod | 3 years | |||||||
SFDR | - | |||||||
NAV Frequency | Daily | |||||||
Investor: Types |
| |||||||
Investor: Knowledges |
| |||||||
Investor: Objectives |
|
Fees
Entry Fees | 3% |
---|---|
Exit Fees | 0% |
Management fees | 1.79% |
Transaction Costs | 0.20439% |
Perf. Fees | - |
Actors
Management company | Nordea Investment Funds S.A. |
---|---|
LEI of the management company | - |